Cleared Traditional

K113018 - APOLLO V+ MEDICAL PLATFORM, APOLLO IV+ MEDICAL PLATFORM, NICE STATION LIGHT BASED PLATFORM

K113018 is an FDA 510(k) clearance for APOLLO V+ MEDICAL PLATFORM, manufactured by Beijing Syntech Laser Co., Ltd.. The device is a Class 2 General & Plastic Surgery device with product code GEX cleared through the Traditional 510(k) pathway after a 430-day FDA review.

K113018 · Beijing Syntech Laser Co., Ltd. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2012
Decision
430d
Days
Class 2
Risk

K113018 is an FDA 510(k) clearance for the APOLLO V+ MEDICAL PLATFORM, APOLLO IV+ MEDICAL PLATFORM, NICE STATION LIGHT B.... Classified as Powered Laser Surgical Instrument within the GEX classification (a category for powered laser surgical instruments across multiple specialties), Class II - Special Controls.

Submitted by Beijing Syntech Laser Co., Ltd. (Shanghai, CN). The FDA issued a Cleared decision on December 14, 2012 after a review of 430 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4810 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General & Plastic Surgery submissions.

View all Beijing Syntech Laser Co., Ltd. devices

FDA 510(k) Submission Details - K113018

510(k) Number K113018 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 11, 2011
Decision Date December 14, 2012
Days to Decision 430 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Regulatory Context
Review time vs. panel average
315d slower than avg
Panel avg: 115d · This submission: 430d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

GEX Device Classification - Class 2, Special Controls

Product Code GEX Powered Laser Surgical Instrument
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4810
Definition A Laser (light Amplification By Stimulated Emission Of Radiation) Based Device Having Coherence, Collimated And Typically Monochromatic Radiation. Typically Indicated To To Cut, Destroy, Remove Or Coagulate Tissue, Generally Soft Tissue, For General Surgical Purpose In Medical Specialties Of General And Plastic Surgery, Dermatology/aesthetic, Podiatry, Otolaryngology (ent), Gynecology, Neurosurgery, Orthopedics (soft Tissue), Dental And Oral Surgery, And Dentistry. The Classification Regulation 21 Cfr 878.4810 Describes A Device That Is Carbon Dioxide Or Argon Laser Intended To Cut, Destroy, Remove Or Coagulate Tissue By The Light.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - GEX Powered Laser Surgical Instrument

All 1723
Devices cleared under the same product code (GEX) and FDA review panel - the closest regulatory comparables to K113018.
DORNIER MEDILAS H30 SOLVO
K122159 · Dornier Medtech America, Inc. · Feb 2013
VITRA MULTISPOT
K122251 · Quantel Medical · Jan 2013
Q-PLUS T+ IPL LASER SYSTEM
K123168 · Quanta System Spa · Dec 2012
MEDILAS H LASER FIBERS
K123385 · Dornier Medtech America, Inc. · Dec 2012
PICOSURE WORKSTATION
K121346 · Cynosure, Inc. · Nov 2012
EPIC 10
K121286 · Biolase Technology, Inc. · Sep 2012